Key Points The Invesco Nasdaq Biotechnology ETF carries a lower expense ratio and delivered higher total returns over the trailing 12 months than the iShares U.S. Healthcare ETF. The iShares U.S. Healthcare ETF provides broader industry diversification across the medical sector, while the Invesco Nasdaq Biotechnology ETF focuses strictly on biotechnology and pharmaceuticals. The iShares U.S. Healthcare ETF has experienced significantly lower maximum drawdowns historically and manages a much larger assets under management (AUM) total. 10 stocks we like better than iShares Trust - iShares U.s. Healthcare ETF › The Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) offers a lower-cost, concentrated play on biotech and pharma, while the iShares U.S.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。